BIOMAT Database Logo BIOMAT Database Logo

Acute pancreatitis during oral 5-aminosalicylic acid therapy. 1990

M T Fiorentini, and M Fracchia, and G Galatola, and A Barlotta, and M de la Pierre
Divisione di Gastroenterologia, Ospedale Mauriziano Umberto I di Torino, Italy.

Therapy with oral 5-aminosalicylic acid for inflammatory bowel disease has been reported as effective and safe. We report two cases of biochemically proven mild acute pancreatitis occurring 2 and 14 days, respectively, after oral 5-aminosalicylic acid therapy was instituted for inflammatory bowel disease. A hypersensitivity mechanism might be involved, owing to possible erratic systemic absorption of the drug. We suggest clinical and biochemical monitoring for patients undergoing oral 5-aminosalicylic acid therapy in order to confirm its possible association with acute pancreatitis and to assess the actual incidence of such an adverse reaction.

UI MeSH Term Description Entries
D008297 Male Males
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D003424 Crohn Disease A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients. Colitis, Granulomatous,Enteritis, Granulomatous,Enteritis, Regional,Ileitis, Regional,Ileitis, Terminal,Ileocolitis,Crohn's Disease,Crohn's Enteritis,Inflammatory Bowel Disease 1,Regional Enteritis,Crohns Disease,Granulomatous Colitis,Granulomatous Enteritis,Regional Ileitides,Regional Ileitis,Terminal Ileitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000636 Aminosalicylic Acids A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions. Acids, Aminosalicylic
D019804 Mesalamine An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed) 5-Aminosalicylate,Mesalazine,5-Aminosalicylic Acid,Asacol,Asacolon,Ascolitin,Canasa,Claversal,Fivasa,Lixacol,Mesalamine Hydrochloride,Mesalamine Monosodium Salt,Mesasal,Novo-5 ASA,Pentasa,Rowasa,Salofalk,m-Aminosalicylic Acid,meta-Aminosalicylic Acid,5 Aminosalicylate,5 Aminosalicylic Acid,Hydrochloride, Mesalamine,Monosodium Salt, Mesalamine,Novo 5 ASA,m Aminosalicylic Acid,meta Aminosalicylic Acid

Related Publications

M T Fiorentini, and M Fracchia, and G Galatola, and A Barlotta, and M de la Pierre
Acute pancreatitis after long-term 5-aminosalicylic acid therapy.
December 1997, The American journal of gastroenterology,
M T Fiorentini, and M Fracchia, and G Galatola, and A Barlotta, and M de la Pierre
[5-Aminosalicylic acid-induced acute pancreatitis].
January 1999, Gastroenterologia y hepatologia,
M T Fiorentini, and M Fracchia, and G Galatola, and A Barlotta, and M de la Pierre
[Acute pancreatitis due to 5-aminosalicylic acid].
March 1991, Revista espanola de enfermedades digestivas,
M T Fiorentini, and M Fracchia, and G Galatola, and A Barlotta, and M de la Pierre
[5-aminosalicylic acid-associated pancreatitis].
July 1991, Deutsche medizinische Wochenschrift (1946),
M T Fiorentini, and M Fracchia, and G Galatola, and A Barlotta, and M de la Pierre
[Pancreatitis associated with 5-aminosalicylic acid].
April 1991, Deutsche medizinische Wochenschrift (1946),
M T Fiorentini, and M Fracchia, and G Galatola, and A Barlotta, and M de la Pierre
Pancreatitis induced by 5-aminosalicylic acid.
August 1989, Lancet (London, England),
M T Fiorentini, and M Fracchia, and G Galatola, and A Barlotta, and M de la Pierre
Acute pancreatitis secondary to 5-aminosalicylic acid therapy in a patient with ulcerative colitis.
June 1999, International journal of pancreatology : official journal of the International Association of Pancreatology,
M T Fiorentini, and M Fracchia, and G Galatola, and A Barlotta, and M de la Pierre
Acute pancreatitis in a child with idiopathic ulcerative colitis on long-term 5-aminosalicylic acid therapy.
January 2000, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
M T Fiorentini, and M Fracchia, and G Galatola, and A Barlotta, and M de la Pierre
Pancreatitis after rectal administration of 5-aminosalicylic acid.
April 1990, Journal of clinical gastroenterology,
M T Fiorentini, and M Fracchia, and G Galatola, and A Barlotta, and M de la Pierre
Oral 5-aminosalicylic acid therapy for mild-to-moderate ulcerative colitis.
November 2010, Journal of the American Academy of Nurse Practitioners,
Copied contents to your clipboard!